Lenalidomide Combined with Interferon α-1b and Interleukin-2 in the Treatment of 21 Cases of Acute Myeloid Leukemia

Turk J Haematol. 2021 Aug 25;38(3):230-232. doi: 10.4274/tjh.galenos.2021.2020.0050. Epub 2021 May 18.
No abstract available

Keywords: Acute myeloid leukemia; Refractory/relapsed; Minimal residual disease; Lenalidomide; Interferon α-1b; Interleukin-2.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
  • Humans
  • Interferon-alpha / therapeutic use
  • Interleukin-2 / therapeutic use
  • Lenalidomide / therapeutic use
  • Leukemia, Myeloid, Acute* / drug therapy

Substances

  • Interferon-alpha
  • Interleukin-2
  • Lenalidomide